Authors: Kimberley Ndungu (Future Science Group)
A team of researchers from the University of Sheffield (UK) has discovered that a potent bacterial toxin, called lysostaphin, is able to target and kill MRSA. The toxin, therefore, may have the potential to provide a new treatment against superbugs.
In the study published in Nature Chemical Biology, the enzyme lysostaphin’s ability to recognize MRSA cell walls and cause the quick breakdown of the pathogen was explained.
Restricted Content / Members Only
